British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of...
from NDTV News - Special https://ift.tt/3aCYrCE
Subscribe to:
Post Comments (Atom)
Popular Posts
-
By BY THE NEW YORK TIMES from NYT U.S. https://ift.tt/2JDppgp
-
By ELLEN GABLER from NYT U.S. https://nyti.ms/2KefSxQ
Oxford Covid Vaccine Less Effective Against South African Variant: Study
British drugmaker AstraZeneca said on Saturday its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of...
from NDTV News - Special https://ift.tt/3aCYrCE
from NDTV News - Special https://ift.tt/3aCYrCE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment